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Abstract
Background: Bovine articular cartilage is often used to study chondrocytes in vitro. It is difficult to
correlate in vitro studies using bovine chondrocytes with in vivo studies using other species such as
rabbits and sheep. The aim of this investigation was to study the effect of species, anatomical
location and exogenous growth factors on chondrocyte proliferation in vitro.
Methods:  Equine (EQ), bovine (BO) and ovine (OV) articular chondrocytes from
metacarpophalangeal (fetlock (F)), shoulder (S) and knee (K) joints were cultured in tissue culture
flasks. Growth factors (rh-FGFb: 10 ng/ml; rh-TGFβ : 5 ng/ml) were added to the cultures at days 2
and 4. On day 6, cells were counted and flow cytometry analysis was performed to determine cell
size and granularity. A three factor ANOVA with paired Tukey's correction was used for statistical
analysis.
Results: After 6 days in culture, cell numbers had increased in control groups of EQ-F, OV-S, OV-
F and BO-F chondrocytes. The addition of rh-FGFb led to the highest increase in cell numbers in
the BO-F, followed by EQ-F and OV-S chondrocytes. The addition of rh-TGFβ  increased cell
numbers in EQ-S and EQ-F chondrocytes, but showed nearly no effect on EQ-K, OV-K, OV-S, OV-
F and BO-F chondrocytes. There was an overall difference with the addition of growth factors
between the different species and joints.
Conclusion: Different proliferation profiles of chondrocytes from the various joints were found.
Therefore, we recommend performing in vitro studies using the species and site where subsequent
in vivo studies are planned.
Background
In vitro studies regarding chondrocyte metabolism and
expansion are often performed using bovine chondro-
cytes [1-3]. These chondrocytes are harvested from the
metacarpophalangeal (fetlock) joint of slaughter-age cat-
tle (18 months old or younger), since the distal limb is not
used for meat production. However, in vivo animal studies
not only tend to be performed in other animals, such as
rabbits [4-9] and sheep [10-14], but also tend to use a dif-
ferent joint. Rather than the fetlock joint used in in vitro
studies, the knee joint is used for in vivo animal studies
[11,12], since it is frequently affected by osteoarthritis in
humans [15,16].
Animal models of osteoarthritis are used as a bridge
between mechanistic cell biology studies and phase 1
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trials in human patients [17,18]. In most cases, laboratory
animals such as the rabbit are used for initial studies
because of their small size, low cost and faster progression
of osteoarthritis. However, lapine (rabbit) cartilage is very
thin, the tissue available for analysis is limited and this
species retains intrinsic repair abilities at maturity
[19,18,20]. Furthermore, smaller laboratory animals
maintain a markedly flexed knee joint position at rest,
whereas larger species have knee joint angles that are
closer to that of the human knee [21]. It is therefore com-
mon that larger animals such as sheep, goats or horses are
used to establish efficacy in models where serial synovial
fluid analysis, topographical analysis of joint cartilage,
and semi-invasive surgery are possible. It thus can be seen
that in vitro and in vivo animal studies seldom use cartilage
from the same species and anatomic location.
There are numerous cartilage repair treatments, including
cell-based strategies such as the implantation of autolo-
gous chondrocytes (ACI) or engineered tissues [22]. ACI is
performed with chondrocytes taken from a small biopsy,
which are expanded in vitro [23]. Growth factors are added
to chondrocyte cultures to prevent de-differentiation and
to increase cell numbers [24,8,25,26]. It has been found
that chondrocytes in the ankle and knee joints react differ-
ently to cytokine stimulation (IL-1) in rats and humans
[27,28]. However, not much is known about the effect of
growth factors on chondrocytes from different anatomical
locations. In this study, two different growth factors were
used in chondrocyte cultures: transforming growth factor
β  (TGFβ ) and basic fibroblast growth factor (FGFb).
Transforming growth factor β  (TGF-β 1) is a pleiotropic
cytokine that has many effects on chondrocytes. TGF-β 1
can control cell proliferation, differentiation, and extracel-
lular matrix (ECM) synthesis, as well as the biological
activities of other growth factors [29]. Its effects on articu-
lar chondrocyte proliferation can be either stimulatory or
inhibitory, depending on culture conditions, time of TGF-
β 1 addition to the culture, and state of cellular differenti-
ation. Vivien et al. [30] and Fortier et al. [31] showed that
TGF-β 1 inhibited the growth of cells with 2% foetal calf
serum (FCS), whereas TGF-β 1 in media with 10% FCS
caused a growth increase. Furthermore, the number, type
and specificity of cytokine receptors, and their reaction to
stimuli, may vary between joints. It has been shown that
the size of the type II TGF-β  receptor differs between
freshly isolated and cultured bovine chondrocytes by 15
kD [32]. Also, Glansbeek et al. [2] found a species specific
difference in chondrocyte expression of type II TGF-β
receptor isoforms between murine, human and bovine
cartilage. The murine cartilage taken from the patella
expressed almost equal amounts of TGF-β bRII1 and TGF-
β bRII2 mRNA, while human cartilage from femoral con-
dyles expressed about three times more TGF-β bRII1 than
TGF-β bRII2. In bovine articular cartilage from the meta-
carpophalangeal joint, only mRNA of TGF-β bRII1 was
found. Studies have shown that in lapine chondrocytes,
expression of TGF-β 1 receptor systems is dependent on
the stage of the cell cycle [30].
Basic fibroblast growth factor (FGFb) has been shown to
prevent chondrocyte de-differentiation in culture [3] and
decrease the doubling time of chondrocytes in monolayer
cultures [33,25]. Chondrocytes, which have become
fibroblast-like cells, are elongated and contain a distinct F-
actin fibrillar structure. Martin et al. [3] concluded that
chondrocytes treated with FGFb did not develop thick F-
actin fibers, but instead had F-actin configurations resem-
bling those of differentiated chondrocytes. The F-actin
configuration is important since it influences the shape of
the chondrocytes. FGFb was found to have a positive
effect on lapine chondrocytes embedded in agarose grafts.
These grafts produced better results in a modified histo-
logical O'Driscoll score compared to TGFβ  or BMP treated
agarose grafts [8].
This investigation studied the effect of species, anatomical
location, and exogenous growth factors on chondrocyte
proliferation in vitro. The large animal species and sites
commonly used for harvesting chondrocytes chosen for
this study were: the equine and ovine knee, shoulder and
fetlock joints, as well as bovine fetlock joints. Equine car-
tilage was included in the study because the equine knee
joint can be affected by naturally occurring disease. Fur-
thermore, its thickness, which is similar to that of the
human knee, allows for surgical manipulations [34,35].
The ovine knee is a common animal model used for carti-
lage repair studies [36,12]. The ovine shoulder joint pro-
vides more cartilage for in vitro studies than the fetlock
joint and was also used as a third joint for comparison.
The equine and ovine fetlock joints were compared to the
bovine fetlock joint since it is commonly used for in vitro
studies.
Methods
Chondrocytes and culture
Articular cartilage was harvested under sterile conditions
from equine (EQ) and ovine (OV) shoulder (S), knee (K)
and fetlock (F) joints, as well as from bovine (BO) fetlock
joints within 24 h of death (Table 1). Animals between 1
– 8 years of age were available from the necropsy room or
slaughterhouse, respectively. The animals had no joint or
systemic disease (such as endotoxemia), which could
affect chondrocyte metabolism. Cartilage samples from
donors of different ages were not pooled.
The chondrocyte isolation protocol was the same in all
species. Cartilage was removed from articular surfaces,
washed with DMEM/F-12 (Invitrogen™, Burlington,BMC Musculoskeletal Disorders 2005, 6:23 http://www.biomedcentral.com/1471-2474/6/23
Page 3 of 8
(page number not for citation purposes)
Canada) containing 100 U penicillin, 100 µg streptomy-
cin and 0.25 µg amphotericin B (Invitrogen™, Burlington,
Canada), then minced into 1 × 2 mm pieces. The cartilage
pieces were incubated with pronase E (Sigma, Oakville,
Canada) (25 U/ml DMEM/F-12, and 8 ml/g cartilage) for
1.5 h at 37°C and 5% CO2, washed, and digested with
bacterial collagenase type II (Sigma, Oakville, Can-
ada)(400 U/ml DMEM/F-12 + 10 % foetal bovine serum
(FBS)(Sigma, Oakville, Canada) and 8 ml/ g cartilage) for
3 h at 37°C and 5 % CO2. The cells were separated from
undigested material through a sieve, centrifuged at 200 ×
g for 10 minutes to form a pellet, washed twice and resus-
pended with DMEM/F-12 + 10 % FBS. Cells were seeded
at a density of 0.5 × 106/ml (± 0.025 × 106/ml) and 4 ml
DMEM/F-12 + 10 % FBS per 25 cm2 flask.
Growth factors
After 2 days in culture, the media was changed and either
10 µg/ml recombinant human basic fibroblast growth fac-
tor (rhFGF-b) (R & D Systems, Inc., Minneapolis, USA), 5
µg/ml recombinant transforming growth factor β  (rhTGF-
β ) (R & D Systems, Inc., Minneapolis, USA) or both fac-
tors were added twice every other day. Chondrocytes with-
out added growth factors served as a control. The media in
the control groups was changed at the same time as that
in the growth factor treated groups. In each experiment,
each group consisted of two flasks, except for chondro-
cytes from the ovine fetlocks. Due to the size of the ovine
fetlock joint, fewer cells were collected, thus producing
only one flask.
Cell count
On day 6, the culture was 80–90% confluent and the
chondrocytes were removed from all culture flasks by
trypsinization, centrifuged at 200 × g for 10 minutes and
washed twice with DMEM/F-12 medium. Day 6 was cho-
sen for this procedure because the de-differentiation of
chondrocytes, which has been observed in monolayer cul-
tures, is still not very advanced at this stage [33,37]. The
collagen type II to collagen type I ratio as an indicator for
de-differentiation experienced the biggest changes in
monolayer cultures between weeks 1 and 2 [37]. Before
proceeding with further experiments, the influence of
growth factors and cell culture conditions on the first pas-
sage was assessed. Cell count and cell viability were per-
formed with the trypan blue exclusion test.
Flow cytometry
Flow cytometry analysis of fluorescent dye labelled
chondrocytes (data not shown) stimulated with FGFb and
TGF-β 1 revealed an influence of the growth factors on cell
size and granularity. The morphological profile of a cell
can be observed by combining forward light scatter (FSC)
and orthogonal or side light scatter (SSC). The FSC meas-
urement is related to the cell size and can change through
cell cycle progression and activation. Measurement of
light scattered at a 90° angle, SSC, is related to internal
granularity. Changes in these parameters were also found
in the non-labelled cells and therefore flow cytometry
analysis was performed in this investigation to study
influence of growth factors on cell activation (Figure 1).
Changes in cell morphology were confirmed with a cyt-
ospin slide preparation of the chondrocytes stained with
Wright's stain (Figure 2). The cell size and granularity were
analysed by flow cytometry with 0.5 × 106/ml cells in
serum-free DMEM/F-12. The analyses were performed
with a FACScan (Becton Dickinson, Oakville, Canada) by
gating 10,000 events. The settings were as follows: excita-
tion: 488 nm; emission: 585 nm; forward side scatter (x -
axis) – photodiode voltage set to E00, AmpGain set to
1.00, Lin; side scatter (y - axis) – photo multiplier voltage
set to 410, AmpGain 1.12, Lin. The same settings were
used throughout the whole experiment for all species and
joints. The results of FSC and SSC measurements are given
in the mean value of channels. A channel is a measured
value of a parameter, representing the signal intensity of
an event after amplification. To appear on a plot (FSC: x-
axis; SSC: y-axis), data for an event must fall into one of
1024 channels. The mean value is calculated from 10,000-
gated events. A conversion from the channel value to cell
size in µm was not performed.
Statistical analysis
A random block design was used in this study. The cell
proliferation rate (increase in cell numbers), cell size and
cell granularity of growth factor treated chondrocytes were
compared to chondrocytes free of any treatment (control
group). The results of the equine and ovine shoulder and
knee joints were analysed separately from bovine, equine
and ovine fetlock joints. A three factor ANOVA with
paired Tukey's Correction was used for statistical analysis.
The level of significance was p ≤  0.05.
Results
Cell number
After 6 days in culture, cell numbers had increased slightly
in control groups for EQ-F (equine fetlock), OV-S (ovine
shoulder), OV-F (ovine fetlock) and BO-F (bovine fet-
lock) chondrocytes in contrast to EQ-K (equine knee),
Table 1: Distribution of sample collection
Sheep (OV) Horse (EQ) Cattle (BO)
Knee (K) 2 5 0
S h o u l d e r  ( S ) 430
Fetlock (F) 3 3 3BMC Musculoskeletal Disorders 2005, 6:23 http://www.biomedcentral.com/1471-2474/6/23
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EQ-S (equine shoulder), and OV-K (ovine knee), where
no increase in cell numbers was found. The cell viability
was over 95 % similar to chondrocyte viability immedi-
ately after isolation. Chondrocyte monolayer cultures had
variable proliferation profiles after the addition of FGFb
and/or TGF- β . The addition of FGFb led to a significant
increase in cell numbers for all species and joints (Table
2). The highest increase in cell count was found in BO-F,
followed by EQ-F and OV-S chondrocytes cultures, as
compared to the control groups. The addition of TGF-β
increased cell numbers significantly in EQ-F (p = 0.0004)
and in EQ-S (p = 0.0002) chondrocyte cultures, but
showed nearly no mitogenic effect on EQ-K, OV-K, OV-S,
OV-F and BO-F chondrocytes. Addition of both growth
factors (FGFb and TGF-β 1) to equine chondrocytes from
all tested joints resulted in a higher increase in cell num-
bers compared to that from the addition of FGFb alone. In
contrast to these findings, increases in cell numbers were
Density plots (FACS) of equine chondrocytes after 6 days in culture and/or two stimulations with growth factors (FSC: for- ward scatter (size); SSC: sideward scatter (granularity)) Figure 1
Density plots (FACS) of equine chondrocytes after 6 days in culture and/or two stimulations with growth factors (FSC: for-
ward scatter (size); SSC: sideward scatter (granularity))
Cytospin slide preparation of equine chondrocytes stained with Wright's stain (Mag. 100×) Figure 2
Cytospin slide preparation of equine chondrocytes stained with Wright's stain (Mag. 100×)
Control group rhTGF-ß rhFGFb rhTGF-ß1/rhFGFb
Control group rhTGF-ß1 rhFGFb rhTGF-ß1/rhFGFbBMC Musculoskeletal Disorders 2005, 6:23 http://www.biomedcentral.com/1471-2474/6/23
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lower in ovine and bovine chondrocyte cultures when
both growth factors were added, compared to the addi-
tion of FGFb alone.
Equine fetlock chondrocytes responded with the largest
cell expansion to the addition of FGFb and FGFb/TGF-β
whereas the knee chondrocytes expressed the lowest reac-
tion to the growth factors. In the ovine species, the growth
factors had the greatest effect on shoulder chondrocytes
and fetlock chondrocytes, whereas knee chondrocytes
responded with a lower proliferation rate. The bovine spe-
cies showed the highest proliferation rate of all the tested
species with respect to stimulation of fetlock chondro-
cytes with FGFb.
Cell proliferation rate of chondrocytes is age dependent.
In this study, specimens from animals over 1 year of age
were used and a trend of higher proliferation rates in
younger animals was present, when compared to the
older animals (up to 8 years of age). The influence of age
on cell proliferation was significant, when data from ani-
mals < 1 year old were included (data not shown). Age did
not influence the species and anatomical location
differences or the chondrocyte reaction to growth factor
treatment.
Cell size
Chondrocyte cell size was given in mean value of channels
and was affected by the addition of growth factors (Table
2). FGFb (p = 0.0033), and the combination of both fac-
tors (p = 0.0008) increased the cell size significantly in
EQ-K chondrocytes. Equine shoulder chondrocytes were
significantly smaller after treatment with TGF-β 1, com-
pared to control cells. In contrast to the equine species,
the cell size in ovine shoulder and knee chondrocytes
increased significantly after the addition of TGF-β 1 to the
culture, as compared to the control groups. The average
ovine fetlock chondrocyte was significantly smaller after
the treatment with FGFb (p = 0.0343). Combined treat-
ment with both growth factors led to larger shoulder (p <
0.0001) and knee (p = 0.0041) chondrocytes in the ovine
species. All treatments in bovine cultures resulted in sig-
nificantly smaller chondrocytes (FGFb: p = 0.036; TGF-β 1:
p = 0.001; FGFb/TGF-β 1: p < 0.0001). An interesting addi-
tional observation, without further investigation, was that
the ovine chondrocytes were generally larger and more
granular than the equine chondrocytes.
Cell granularity
After the treatment with FGFb, all chondrocytes, except
EQ-K, showed a significant decrease in cell granularity
(Table 2). The same results were found for the combined
treatment trials, except for the OV-S chondrocytes. The
addition of TGF-β 1 to the EQ-K and OV-S chondrocyte
cultures resulted in an increase of granularity. Correlation
between cell number, size and granularity was analysed
using the Pearson Correlation Test and no relevant corre-
lation was found.
Discussion
Distinctions in cartilage, related to anatomical location
(i.e. from knee and ankle joints), in regard to catabolism
have been found [38]. Furthermore, the frequency of
human osteoarthritis (OA) differs between joints. It is
most common in the hands, knees and hips, while occur-
ring less frequently in ankle and shoulder joints [16,38].
Dieppe and Kirwan [16] listed several factors that influ-
ence susceptibility and severity of osteoarthritis. Several
authors have reported differences between joints [27,38],
but this factor is not always considered when observations
from in vitro studies are transferred to in vivo studies. This
investigation details the influence of species and anatom-
ical location on chondrocyte proliferation, as well as the
influence of growth factors on chondrocytes from differ-
ent joints and animals.
Isolated chondrocytes are used for cartilage repair in
human patients [23] and in tissue engineering. These
Table 2: Comparison of cell number, cell size and granularity of 
growth factors treated chondrocytes to control groups
Cell number FGFb TGF-β 1F G F b / T G F - β 1
EQ-F 0.003 ↑ 0.0004 ↑ < 0.0001 ↑
EQ-S 0.0031 ↑ 0.0002 ↑ < 0.0001 ↑
EQ-K 0.1500 0.7494 0.0077 ↑
OV-F 0.016 ↑ 0.667 0.153
OV-S < 0.0001 ↑ 0.8037 0.0204 ↑
OV-K 0.1223 0.4245 0.1249
BO-F < 0.0001 ↑ 0.964 < 0.0001 ↑
Cell size
EQ-F 0.4983 0.4709 0.2509
EQ-S 0.8786 0.0061 ↓ 0.2194
EQ-K 0.0033 ↑ 0.4283 0.0008 ↑
OV-F 0.0343 ↓ 0.4044 0.9033
OV-S 0.6132 < 0.0001 ↑ < 0.0001 ↑
OV-K 0.4310 0.0041 ↑ 0.0041 ↑
BO-F 0.036 ↓ 0.001 ↓ < 0.0001 ↓
Cell granularity
EQ-F 0.0015 ↓ 0.0514 0.0009 ↓
EQ-S 0.0074 ↓ 0.2470 0.0020 ↓
EQ-K 0.0995 0.0098 ↑ 0.0273 ↓
OV-F < 0.0001 ↓ 0.0996 < 0.0001 ↓
OV-S 0.0092 ↓ 0.0005 ↑ 0.1356
OV-K 0.0008 ↓ 0.3767 0.0009 ↓
BO-F < 0.0001 ↓ 0.6367 < 0.0001 ↓
↑  : significant increase
↓  : significant decreaseBMC Musculoskeletal Disorders 2005, 6:23 http://www.biomedcentral.com/1471-2474/6/23
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techniques rely on in vitro expansion of chondrocytes
from small biopsies. The goal is to expand the chondro-
cytes quickly and to maintain their chondrogenic poten-
tial and their ability to re-differentiate. To this end,
different growth factors and growth factor combinations
have been tested [33]. However, the differences related to
anatomical location of the knee and hip chondrocytes
were not accounted for [33]. In tissue engineering, cells
are placed in a three dimensional matrix to form new car-
tilage [39,40,25]. However, the newly formed tissue can
vary from species to species, despite the fact that the
chondrocytes were taken from the same anatomical loca-
tion [39]. These studies involved the encapsulation of
bovine and ovine chondrocytes into a photo-polymeris-
ing hydrogel system and it was found that bovine
chondrocytes produced more glycosaminoglycans,
whereas the cell number increased in the ovine constructs.
It was evident in our study that chondrocytes from the fet-
lock have a higher proliferation rate than chondrocytes
from the knee joint in horses, as well as in sheep. This
result indicates that the chondrocyte cell cycle varies
according to species and location. The doubling time of
human chondrocytes in monolayer cultures ranges
between 1.7 to 3.5 days [23,33], while in equine and
bovine chondrocytes it is 5 – 6 days [41,1]. In our study,
doubling of the chondrocytes could not be achieved
within the 6-day culture time for the control groups. It
would be of interest to study several time points to evalu-
ate changes over time and find the optimal time point for
the addition of growth factors and their combination for
chondrocyte expansion. When several time points are
studied, the differentiation state of the cells has to be con-
sidered, because the de-differentiation progress in monol-
ayer culture changes dramatically between the first and
second week [37].
Age and culture conditions are also factors to consider
when working with isolated chondrocytes. Age is an
important factor, since young animals and young humans
have chondrocytes that proliferate much faster than
chondrocytes from older animals and humans [22,26].
The influence of age on the proliferation rate was
observed to be significant when analysing data obtained
from young animals (data not shown). In animals over 1
year of age, a trend of higher proliferation rates in younger
animals was present, when compared to the older animals
(up to 8 years), but age did not influence the species and
anatomical location differences or the chondrocyte reac-
tion to growth factor treatment. Therefore, in this study,
only specimens from animals over 1 year of age were
taken, because at this age their growth is no longer expo-
nential [42]. Sheep, horses and cattle reach skeletal matu-
rity at the age of 3–4 years [43,44]. Preliminary
experiments showed that cell number could not be main-
tained at a steady state in the control group without the
addition of FBS. Thus 10% FBS was added to the chondro-
cyte cultures. When chondrocytes are expanded for later in
vivo use, they are cultured with homologous serum. This
was not an option in this study because the specimens
were retrieved from the necropsy room or slaughterhouse.
Chondrocytes modify their cell shape from round to flat
in monolayer cultures and increase their DNA synthesis
[45]. Lee et al. [1] suggest that these cell shape changes
affect responsiveness to IGF-1 due to receptor level
changes or affinity of the receptors in flattened cells. A
change of cell size and granularity was found after cells
were twice treated with growth factors FGFb and TGF-β 1,
which are indicators for different cell activation stages.
Further investigations are necessary to study the influence
of cell size and granularity changes on intracellular signal-
ling. Changes in granularity can be caused by an engorged
endoplasmatic reticulum, as a consequence of increased
intracellular protein production.
It should be noted that human recombinant growth fac-
tors were also used in this study, since only bovine FGFb
is available. The amino acid homology between human
growth factors FGFb and TGF-β 1 and the tested animals is
above the 60 % threshold, which is necessary for cross-
reaction between species [46]. Furthermore, FGFb and
TGF- β 1 belong to the β -sheet based folds family, which
makes cross-reaction between species more likely, since
these are highly conserved cytokines. The amino acid
homology to human growth factors is 98% for equine,
97% for ovine and 98% for bovine FGFb and 84% for
equine, 87% for ovine and 86% for bovine TGFβ -1.
Increased biological activity may be more influenced by
the receptor binding capacity and efficiency [46]. If the
differences in cell proliferation were related to species-
specific cytokine – receptor-binding interaction, the same
proliferation pattern within the tested species would be
found. It is very unlikely that the same growth factor inter-
acts with cell surface receptors differently in different
joints within one species. Rather, the inconsistent results
between joints of the same species indicate the presence of
different numbers of receptors on the cell surface.
The varying response between joints can also be due to
different types or number of receptors per cell. Bovine fet-
lock chondrocytes express only one type of TGF-β  receptor
(TGF-β bRII1) in contrast to murine and human knee
chondrocytes, which express two types of receptors (TGF-
β bRII1 and TGF-β bRII2) [2]. The expression rate of the
TGF-β bRII receptor is higher in freshly isolated bovine
metacarpophalangeal chondrocytes as compared to cul-
tured chondrocytes [47]. These findings indicate that time
of treatment may influence receptor expressions. It would
be of interest to study whether the changes in receptorBMC Musculoskeletal Disorders 2005, 6:23 http://www.biomedcentral.com/1471-2474/6/23
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density could be avoided by three dimensional chondro-
cyte cultures.
A synergistic effect of TGF-β 1 and FGFb is reported in the
proliferation rate of human hip and ankle [33], as well as,
in lapine knee chondrocytes [48]. In our study, the same
effect was found on equine chondrocytes from all tested
joints. In contrast, ovine chondrocytes from the various
joints and the bovine fetlock chondrocytes did not dem-
onstrate this effect. The proliferation rate in ovine and
bovine chondrocyte cultures with the addition of both
growth factors was lower than the cultures with FGFb
alone. This synergistic effect is species specific, but is not
related to the anatomical location of cartilage origin.
The signal pathways activated by growth factors are com-
plex. TGF-β 1 activates two independent signal pathways,
which lead to the activation of different transcription fac-
tors [49]. It could be speculated that the smaller cell size
is a result of freshly divided cells, but a correlation
between cell number and size was not found in our study.
To investigate the cause of the cell size and granularity
changes after growth factor treatment, further studies such
as cell cycle studies and/or intracellular matrix protein
production studies would be necessary. It would also be
of interest to analyse the type and number of FGFb and
TGF-β  receptors on the cell surface of the chondrocytes
from different joints and their changes over culture time.
A different number of cell surface receptors on chondro-
cytes may suggest that chondrocytes from one joint pro-
duce more matrix than chondrocytes from another joint.
This factor would be an important consideration when
harvesting chondrocytes for tissue engineering. For exam-
ple, a smaller cartilage biopsy from the ankle joint would
be necessary to produce the same amount of new tissue
than a bigger biopsy from the knee joint [38].
Healthy chondrocytes from various joints within the same
species proliferate differently, depending on the addition
or absence of growth factors. This indicates varying capa-
bilities of articular chondrocytes to react to stimuli, which
is further supported by the catabolic differences found
between human ankle and knee cartilage explants [38].
Therefore, one could expect that an in vitro study per-
formed with fetlock chondrocytes regarding cell prolifera-
tion and tissue engineering gives different results when
knee chondrocytes are used. Furthermore, the use of a dif-
ferent species could add another variable. The use of ani-
mal models to establish treatment strategies for
osteoarthritis before clinical studies is very important
since technical application difficulties and the develop-
ment of associated joint pathology would be revealed in
these models [22,20].
Conclusion
The animal model, site and the size of the lesion require
careful consideration in making decisions about treat-
ment strategy [22]. In vitro studies are important to ade-
quately preparing for in vivo testing. Thus, in vitro studies
should be performed using the species and site where sub-
sequent in vivo studies are planned.
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